HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-04-01Clinical Trial Update: Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1:FOVIR+EMTRICITABINA + LOPINAVIR/RITONAVIR VS TENOFOVIR+EMTRICITABINA + MARAVIROC (MARAVI-PEP) [Phase 4]
A Phase 4 clinical trial completed that compared two post-exposure prophylaxis regimens for HIV infection: FOVIR with emtricitabine plus lop…
-
CLINICAL_TRIALS trial_result · 2015-04-01Clinical Trial Update: A Study to Evaluate the Safety of the HIV-1 Vaccine MVA-B in Chronic HIV-1 Infected Patients Successfully Treated With HAART [Phase 1]
A Phase 1 study evaluated the safety of the HIV-1 vaccine MVA-B in chronic HIV-1 infected patients successfully treated with HAART; the tria…
-
CLINICAL_TRIALS trial_result · 2015-04-01Clinical Trial Update: Tenofovir in HIV/HBV Coinfection [Phase 4]
A Phase 4 clinical trial of tenofovir for HIV and hepatitis B coinfection has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-01Clinical Trial Update: Enhancing Communication and HIV Outcomes [Phase 3]
A Phase 3 clinical trial, sponsored by Johns Hopkins University, evaluating an intervention to enhance communication and HIV outcomes has co…
-
CLINICAL_TRIALS trial_result · 2015-04-01Clinical Trial Update: Project Hope: Hospital Visit is an Opportunity for Prevention and Engagement With HIV-positive Crack Users [NA]
A completed trial sponsored by Columbia University aimed at prevention and engagement strategies for HIV-positive individuals who use crack …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-04-01Clinical Trial Update: Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1: Tenofovir + Emtricitabine + Lopinavir/Ritonavir Versus Tenofovir + Emtricitabine + Raltegravir (RAL-PEP) [Phase 4]
A Phase 4 trial comparing two post-exposure prophylaxis regimens for HIV-1 (tenofovir/emtricitabine with lopinavir/ritonavir versus tenofovi…
-
CLINICAL_TRIALS trial_result · 2015-03-31Clinical Trial Update: PK TDF in Thai HIV-infected Children [NA]
A completed clinical trial evaluating the pharmacokinetics of tenofovir disoproxil fumarate (TDF) in Thai HIV-infected children.
-
CLINICAL_TRIALS trial_result · 2015-03-31Clinical Trial Update: Open Label, Pilot Study of Darunavir Boosted by Cobicistat in Combination With Rilpivirine to Treat HIV+ Naïve Subjects [Phase 4]
An open-label Phase 4 pilot trial is evaluating a regimen of darunavir boosted by cobicistat in combination with rilpivirine for treatment-n…
-
CLINICAL_TRIALS research · 2015-03-31Clinical Trial Update: Using Heavy Water to Study Cell Dynamics in Parkinson's Disease
A clinical trial update describes using heavy water to study cell dynamics in Parkinson's disease. HIV infection is also listed as a conditi…
-
CLINICAL_TRIALS trial_result · 2015-03-30Clinical Trial Update: Comparing the Effectiveness Between Ritonavir Boosted Atazanavir and Efavirenz for the First HIV Treatment [Phase 3]
A Phase 3 trial update comparing ritonavir-boosted atazanavir with efavirenz as initial HIV therapy has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-30Clinical Trial Update: Comparison of Epzicom and Truvada for the Initial Once Daily HIV Treatment [Phase 4]
This update reports completion of a Phase 4 trial comparing Epzicom versus Truvada for initial once-daily HIV treatment.
-
CLINICAL_TRIALS trial_result · 2015-03-30Clinical Trial Update: Comparing Continuing Tenofovir, Emtricitabine (or Lamivudine) Plus Lopinavir and Switching to Raltegravir Plus Darunavir [NA]
A completed clinical trial comparing continuing Tenofovir disoproxil fumarate with Emtricitabine (or Lamivudine) plus Lopinavir versus switc…
-
CLINICAL_TRIALS withdrawal · 2015-03-30Clinical Trial Update: Pharmacokinetic and Efficacy of SQV/r 1500/100 Plus Tenofovir/Emtricitabine 300/200 mg [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating saquinavir/ritonavir with tenofovir/emtricitabine in HIV patients has been withdrawn.
-
FDA approval · 2015-03-27FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for KALETRA (lopinavir/ritonavir) submitted by AbbVie Inc.
-
FDA approval · 2015-03-27FDA Approved: APTIVUS — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for APTIVUS (tipranavir) from Boehringer Ingelheim Pharmaceuticals, Inc.
-
FDA approval · 2015-03-27FDA Approved: VIRACEPT — Supplemental Application (AGOURON)
FDA approved a supplemental application for Viracept (nelfinavir mesylate) by Agouron, authorizing changes to the approved product labeling.
-
FDA approval · 2015-03-27FDA Approved: VIRACEPT — Supplemental Application (AGOURON)
The FDA approved a supplemental application for VIRACEPT (nelfinavir mesylate) submitted by Agouron.
-
FDA approval · 2015-03-27FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for KALETRA (lopinavir/ritonavir) from AbbVie Inc. to modify the drug's labeling or indications …
-
FDA approval · 2015-03-27FDA Approved: NORVIR — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for NORVIR (ritonavir) by AbbVie.
-
FDA approval · 2015-03-27FDA Approved: PREZISTA — Supplemental Application (Janssen Products LP)
The FDA approved a supplemental application for Prezista (darunavir) from Janssen Products LP, resulting in updated labeling for the drug.
-
FDA approval · 2015-03-27FDA Approved: REYATAZ — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
The FDA approved a supplemental application for Reyataz (atazanavir) submitted by E.R. Squibb & Sons, L.L.C.
-
FDA approval · 2015-03-27FDA Approved: REYATAZ — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
The FDA approved a supplemental application for REYATAZ (atazanavir) submitted by E.R. Squibb & Sons, L.L.C. This action typically updates l…
-
CLINICAL_TRIALS trial_result · 2015-03-26Clinical Trial Update: Lopinavir/Ritonavir (LPV/r) Tablet in HIV Infected Children [Phase 2]
An update on a Phase 2 trial evaluating the Lopinavir/ritonavir tablet in HIV-infected children, with the study status listed as completed.
-
CLINICAL_TRIALS trial_result · 2015-03-26Clinical Trial Update: Lopinavir/Ritonavir Monotherapy in Children [Phase 4]
Phase 4 trial results update on lopinavir/ritonavir monotherapy in HIV-infected children. The report summarizes safety and efficacy outcomes…
-
CLINICAL_TRIALS withdrawal · 2015-03-26Clinical Trial Update: Bioequivalence Study of Generic GPO Saquinavir and Norvir® Versus Invirase® and Norvir® [Phase 1, Phase 2]
Phase 1/Phase 2 bioequivalence study comparing generic saquinavir with ritonavir to branded saquinavir (Invirase) with ritonavir has been wi…